This HTML5 document contains 171 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n12http://dx.doi.org/10.1002/1521-4141(200101)31:1%3C39::
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q31909336
rdf:type
wikibase:Item
schema:description
vitskapeleg artikkel scientific article سائنسی مضمون מאמר מדעי 2001年論文 мақолаи илмӣ tudományos cikk wissenschaftlicher Artikel 2001 թուականի Յունուարին հրատարակուած գիտական յօդուած ২০০১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artikull shkencor vitenskapelig artikkel 2001年論文 2001年论文 научни чланак научная статья 2001년 논문 مقالة علمية: نشرت في عام 2001 article scientifique (publié 2001) artigo científico teaduslik artikkel 2001年论文 artigo científico (publicado na 2001) vetenskaplig artikel bài báo khoa học vedecký článok სამეცნიერო სტატია 2001年論文 наукова стаття, опублікована в січні 2001 επιστημονικό άρθρο artículu científicu espublizáu en 2001 wetenschappelijk artikel vědecký článek artikulong pang-agham article scientific 2001年論文 2001年論文 videnskabelig artikel (udgivet 2001) научни чланак articol științific article científic artykuł naukowy บทความทางวิทยาศาสตร์ 2001年论文 artículo científico publicado en 2001 scienca artikolo 2001年の論文 научна статия 2001年论文 naučni članak bilimsel makale 2001 nî lūn-bûn 2001年论文 artigo científico (publicado na 2001) 2001年论文 tieteellinen artikkeli мақолаи илмӣ mokslinis straipsnis articolo scientifico 2001 թվականի հունվարին հրատարակված գիտական հոդված مقالهٔ علمی
p:P577
wds:Q31909336-148BF608-29CC-4E15-BC93-D93641AA0CA1
wdt:P577
2001-01-01T00:00:00Z
p:P407
wds:Q31909336-D4673B8C-17B0-4EE8-AA79-B137CCE248EF
wdt:P407
wd:Q1860
p:P2860
wds:Q31909336-FC6A17A8-05DC-485E-A159-65323A42FDC4 wds:Q31909336-ACF41917-3256-4A44-AD5B-3711BE09285F wds:Q31909336-C4698F54-82C4-4A61-AF6D-EB9C3D63373B wds:Q31909336-DB077479-C7F5-4286-9BD2-A0FD67B3D761 wds:Q31909336-E7C961EB-46AB-4203-9F21-176B5FADA450 wds:Q31909336-E80797CF-3300-44CD-9031-D8722FAE7A5E wds:Q31909336-F6150684-6BA3-4FBA-9265-D11DBA60C2B6 wds:Q31909336-FC38FDA5-5548-437B-9F62-232EDC30916E wds:Q31909336-4BF93E52-8294-4574-9C7E-0A21C10F3938 wds:Q31909336-51BC806B-669D-4A5C-9230-686802843696 wds:Q31909336-52FE75BD-2191-4A86-A603-064577C86ECA wds:Q31909336-5603101C-5ECB-4EBC-858A-0E1B471D56EC wds:Q31909336-5AEBFA42-A523-4FE6-A14B-55E649C656A5 wds:Q31909336-5E1D2BBD-3EB0-4DFF-AA45-90D57232BCD6 wds:Q31909336-7812C7FE-C7B6-4A8B-BEAB-0D9A77633BBD wds:Q31909336-781596AA-904E-4029-9308-04E783B7FE4D wds:Q31909336-7D8617DE-8389-4C3E-808E-4DD61C76D43D wds:Q31909336-806A9D3A-F081-471D-BEAA-DD4B14264046 wds:Q31909336-873D3DF0-EBFC-40E7-B76D-2BE31CCEADE3 wds:Q31909336-8F9E9396-9247-4360-9CBD-2892B81EF046 wds:Q31909336-9DF213EE-7FB4-412A-AA34-A7B7D130A8D1 wds:Q31909336-9E058977-5CE2-445A-ACCD-9D78DB8EAF30 wds:Q31909336-00F882CF-D7FD-4376-89E7-807ECA72AED7 wds:Q31909336-0323A0C0-96D3-44E8-AEB3-5E4AFE0C4CD4 wds:Q31909336-05BB426B-C3CE-4996-86B0-B13BA12BC073 wds:Q31909336-07210D29-B301-41C7-B920-474210502563 wds:Q31909336-082BFE15-29C1-4352-A7EF-804F198AE615 wds:Q31909336-101EA688-3900-4BB4-8756-97ECB320A9C3 wds:Q31909336-1B845E6F-C44E-468A-B353-ED0E4DF23B94 wds:Q31909336-1F121FEC-4718-4BDF-8AC0-C13F691B9B03 wds:Q31909336-20A37500-E926-416B-BBA0-4BBA7BB03EC8 wds:Q31909336-211EF9B0-0419-47AC-A753-51E47BC985FB wds:Q31909336-2141AFA0-9696-4DA0-83E1-7A5ED11181D2 wds:Q31909336-2A5C0333-A3E4-444E-B11D-619210B5B155 wds:Q31909336-3BA0A3D3-03E8-4939-BB53-23ED35936A7A wds:Q31909336-4BEEFB5F-FD69-4AF3-B120-962A5E913D43
wdt:P2860
wd:Q33882431 wd:Q73103920 wd:Q57272593 wd:Q28270716 wd:Q54013097 wd:Q43546523 wd:Q36349213 wd:Q37371294 wd:Q36798566 wd:Q36364583 wd:Q36376867 wd:Q59156993 wd:Q51093028 wd:Q33960986 wd:Q36380734 wd:Q36687936 wd:Q36380903 wd:Q36401729 wd:Q36366817 wd:Q73812485 wd:Q54515149 wd:Q40541153 wd:Q36357068 wd:Q36375962 wd:Q28594763 wd:Q54432520 wd:Q36368808 wd:Q36704066 wd:Q77879079 wd:Q41149922 wd:Q24675937 wd:Q40378896 wd:Q57272605 wd:Q40908512 wd:Q37554710 wd:Q36367528
p:P2093
wds:Q31909336-9F4358A5-332D-4842-A23A-B9A44244DFD2 wds:Q31909336-F6FD9C8B-72D5-4747-8E99-EFAE0420FB9F
wdt:P2093
Davis JE Trapani JA
rdfs:label
Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity
skos:prefLabel
Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity
schema:name
Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity
p:P50
wds:Q31909336-B182BA98-A76F-4907-82C2-688B519FA1CA
wdt:P50
wd:Q38544864
p:P1476
wds:Q31909336-C1A3B5FD-AE83-414F-8D6F-44EE12CA42E1
wdt:P1476
Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity
p:P304
wds:Q31909336-C76C692A-7386-4339-B9F4-0B58F62FAE48
wdt:P304
39-47
p:P31
wds:Q31909336-D23B3391-AA6B-4940-9FFC-266021DABF79
wdt:P31
wd:Q13442814
p:P698
wds:Q31909336-77EB9E02-676D-448D-8B73-605352CE1A36
wdtn:P698
n11:11169436
wdt:P698
11169436
p:P1433
wds:Q31909336-FB0E1F1F-3BFB-487B-9DE9-5D243D7AB0B1
wdt:P1433
wd:Q5412727
p:P433
wds:Q31909336-B5E24082-3AF4-4409-81FA-1B78BEE41E79
p:P478
wds:Q31909336-20F6EE47-1B45-4CEC-AE81-FCECE7A27B49
wdt:P433
1
wdt:P478
31
p:P356
wds:Q31909336-9504CCA7-6AF1-4C8A-BB77-3ACF3858C03F
wdtn:P356
n12:AID-IMMU39%3E3.0.CO;2-1
wdt:P356
10.1002/1521-4141(200101)31:1<39::AID-IMMU39>3.0.CO;2-1